Jensen R T, Heinz-Erian P, Mantey S, Jones S W, Gardner J D
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892.
Am J Physiol. 1988 Jun;254(6 Pt 1):G883-90. doi: 10.1152/ajpgi.1988.254.6.G883.
In the present study the ability of two classes of substance P (SP) antagonists to affect SP- and bombesin (Bn)-stimulated amylase release, as well as binding of 125I-Bolton-Hunter (BH)-SP and 125I-[Tyr4]Bn, was studied to determine their mechanism of action and the relationship between inhibition of the action of SP and the action of Bn. Four SP analogues ([D-Pro2,D-Phe7,D-Trp9]SP, [D-Pro2,D-Trp7,9]SP, [D-Arg1,D-Pro2,D-Trp7,9,Leu11]SP, and [D-Arg1,D-Trp7,9,Leu11]SP) and two SP-(4-11) analogues ([D-Pro4,D-Trp7,9]SP-(4-11) and [D-Pro4,D-Trp7,9,10]SP-(4-11)] did not stimulate amylase release when present alone but inhibited SP- and Bn-stimulated amylase release. For each SP analogue, inhibition was specific for peptides that stimulate release by interacting with SP or Bn receptors, whereas both SP-(4-11) analogues also inhibited cholecystokinin-stimulated amylase release. Each SP analogue's inhibition of Bn-stimulated amylase release was reversible. Each analogue inhibited binding of 125I-BH-SP with the same potency as it inhibited SP-stimulated amylase release and 125I-[Tyr4]Bn binding with the same potency as it inhibited Bn-stimulated amylase. In contrast, SP itself or SP-(4-11) itself did not inhibit Bn-stimulated amylase release or binding of 125I-[Tyr4]Bn. The relative affinities of the analogues for interacting with Bn and SP receptors differed. None of the analogues increased the dissociation of bound 125I-BH-SP or 125I-[Tyr4]Bn.(ABSTRACT TRUNCATED AT 250 WORDS)
在本研究中,研究了两类P物质(SP)拮抗剂影响SP和蛙皮素(Bn)刺激的淀粉酶释放以及125I-博尔顿-亨特(BH)-SP和125I-[酪氨酸4]Bn结合的能力,以确定它们的作用机制以及SP作用抑制与Bn作用之间的关系。四种SP类似物([D-脯氨酸2,D-苯丙氨酸7,D-色氨酸9]SP、[D-脯氨酸2,D-色氨酸7,9]SP、[D-精氨酸1,D-脯氨酸2,D-色氨酸7,9,亮氨酸11]SP和[D-精氨酸1,D-色氨酸7,9,亮氨酸11]SP)以及两种SP-(4-11)类似物([D-脯氨酸4,D-色氨酸7,9]SP-(4-11)和[D-脯氨酸4,D-色氨酸7,9,10]SP-(4-11))单独存在时不刺激淀粉酶释放,但抑制SP和Bn刺激的淀粉酶释放。对于每种SP类似物,抑制作用对通过与SP或Bn受体相互作用刺激释放的肽具有特异性,而两种SP-(4-11)类似物也抑制胆囊收缩素刺激的淀粉酶释放。每种SP类似物对Bn刺激的淀粉酶释放的抑制作用是可逆的。每种类似物抑制125I-BH-SP结合的效力与其抑制SP刺激的淀粉酶释放的效力相同,抑制125I-[酪氨酸4]Bn结合的效力与其抑制Bn刺激的淀粉酶的效力相同。相比之下,SP本身或SP-(4-11)本身不抑制Bn刺激的淀粉酶释放或125I-[酪氨酸4]Bn的结合。类似物与Bn和SP受体相互作用的相对亲和力不同。没有一种类似物增加结合的125I-BH-SP或125I-[酪氨酸4]Bn的解离。(摘要截短于250字)